JP2009035545A5 - - Google Patents

Download PDF

Info

Publication number
JP2009035545A5
JP2009035545A5 JP2008178569A JP2008178569A JP2009035545A5 JP 2009035545 A5 JP2009035545 A5 JP 2009035545A5 JP 2008178569 A JP2008178569 A JP 2008178569A JP 2008178569 A JP2008178569 A JP 2008178569A JP 2009035545 A5 JP2009035545 A5 JP 2009035545A5
Authority
JP
Japan
Prior art keywords
weight
amlodipine
stable
jelly
solution according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008178569A
Other languages
Japanese (ja)
Other versions
JP5072748B2 (en
JP2009035545A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2008178569A priority Critical patent/JP5072748B2/en
Priority claimed from JP2008178569A external-priority patent/JP5072748B2/en
Publication of JP2009035545A publication Critical patent/JP2009035545A/en
Publication of JP2009035545A5 publication Critical patent/JP2009035545A5/ja
Application granted granted Critical
Publication of JP5072748B2 publication Critical patent/JP5072748B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (15)

アムロジピン0.1〜1重量%と、硫酸基またはスルホン酸基を有する陰イオン性界面活性剤0.2〜2重量%を含有する、液性がpH5〜7の安定なアムロジピン液剤。 A stable amlodipine solution having a pH of 5 to 7 containing 0.1 to 1% by weight of amlodipine and 0.2 to 2% by weight of an anionic surfactant having a sulfate group or a sulfonate group. 硫酸基を有する陰イオン性界面活性剤がラウリル硫酸ナトリウムである、請求項1記載の安定なアムロジピン液剤。 The stable amlodipine solution according to claim 1, wherein the anionic surfactant having a sulfate group is sodium lauryl sulfate. 非イオン性界面活性剤が添加されている、請求項1または2記載の安定なアムロジピン液剤。 The stable amlodipine solution according to claim 1 or 2, wherein a nonionic surfactant is added. 非イオン性界面活性剤がショ糖脂肪酸エステルである、請求項1〜3のいずれかに記載の安定なアムロジピン液剤。 The stable amlodipine solution according to any one of claims 1 to 3, wherein the nonionic surfactant is a sucrose fatty acid ester. 有機酸が添加されている請求項1〜4のいずれかに記載の安定なアムロジピン液剤。 The stable amlodipine solution according to any one of claims 1 to 4, wherein an organic acid is added. 有機酸が、クエン酸及びそのナトリウム塩の中から一つ又は複数が選択されるものである、請求項1〜5のいずれかに記載の安定なアムロジピン液剤。 The stable amlodipine solution according to any one of claims 1 to 5, wherein the organic acid is one selected from citric acid and a sodium salt thereof. 甘味料として、糖及び/又は糖アルコールが添加されている、請求項1〜6のいずれかに記載の安定なアムロジピン液剤。 The stable amlodipine solution according to any one of claims 1 to 6, wherein sugar and / or sugar alcohol is added as a sweetener. 請求項1〜7のいずれかに記載の安定なアムロジピン液剤を100重量部として、更に0.1〜3重量部のゲル化剤と0.2〜5重量部の微粉末状固形物を添加して得られる、アムロジピンの安定なゼリー剤。 100 parts by weight of the stable amlodipine solution according to any one of claims 1 to 7, and further 0.1 to 3 parts by weight of a gelling agent and 0.2 to 5 parts by weight of a finely powdered solid A stable jelly preparation of amlodipine. ゲル化調節剤が添加されている、請求項8に記載の安定なゼリー剤。 The stable jelly agent according to claim 8, wherein a gelling regulator is added. ゲル化調節剤が塩化カリウムである、請求項8または9に記載の安定なゼリー剤。 The stable jelly agent according to claim 8 or 9, wherein the gelation regulator is potassium chloride. ゲル化剤がカラギーナンであり、液性がpH5〜7の、請求項8〜10のいずれかに記載の安定なゼリー剤。 The stable jelly agent according to any one of claims 8 to 10, wherein the gelling agent is carrageenan and the liquid property is pH 5 to 7. 少なくとも以下の組成からなり、液性がpH5〜7のアムロジピンのゼリー組成物であって、
a)アムロジピン0.1〜1重量%、
b)硫酸基またはスルホン酸基を有する陰イオン性界面活性剤0.2〜2重量%、
c)ゲル化剤0.1〜3重量%、
d)ゲル化調節剤0.1〜2重量%、
e)微粉末状固形物0.2〜3重量%、
であることを特徴とする、アムロジピンの安定なゼリー組成物。
An amlodipine jelly composition having at least the following composition and having a pH of 5 to 7,
a) 0.1 to 1% by weight of amlodipine,
b) 0.2 to 2% by weight of an anionic surfactant having a sulfate group or a sulfonate group,
c) 0.1 to 3% by weight of a gelling agent,
d) 0.1-2% by weight of a gelation modifier,
e) 0.2 to 3% by weight of finely divided solid,
A stable jelly composition of amlodipine, characterized in that
甘味料が15〜50重量%添加されていることを特徴とする、請求項12記載の安定なゼリー組成物。 The stable jelly composition according to claim 12, wherein a sweetener is added in an amount of 15 to 50% by weight. 少なくとも以下の組成からなり、液性がpH6〜7であるアムロジピンのゼリー組成物であって、
a)アムロジピン0.1〜1重量%、
b)硫酸基またはスルホン酸基を有する陰イオン性界面活性剤がラウリル硫酸ナトリウムであり、
c)ゲル化剤がカラギーナンであり、
d)ゲル化調節剤が塩化カリウムであり、
e)微粉末状固形物が結晶セルロースおよび軽質無水ケイ酸であり、
f)甘味料がソルビトールである
ことを特徴とする、請求項12記載のアムロジピンの安定なゼリー組成物。
An amlodipine jelly composition having at least the following composition and having a liquidity of pH 6-7,
a) 0.1 to 1% by weight of amlodipine,
b) the anionic surfactant having a sulfate group or a sulfonate group is sodium lauryl sulfate;
c) the gelling agent is carrageenan;
d) the gelation modifier is potassium chloride;
e) the finely divided solid is crystalline cellulose and light anhydrous silicic acid,
f) Stable jelly composition of amlodipine according to claim 12, characterized in that the sweetener is sorbitol.
少なくとも以下の組成からなり、液性がpH6〜7であるアムロジピンのゼリー組成物であって、
a)アムロジピンが0.1〜1重量%、
b)ラウリル硫酸ナトリウムが0.2〜0.8重量%、
c)カラギーナンが0.5〜2重量%、
d)塩化カリウムが0.2〜1重量%、
e)結晶セルロースおよび軽質無水ケイ酸が0.5〜2重量%、
f)ソルビトールが20〜45重量%、
であることを特徴とする、請求項12記載のアムロジピンの安定なゼリー組成物。
An amlodipine jelly composition having at least the following composition and having a liquidity of pH 6-7,
a) 0.1 to 1% by weight of amlodipine,
b) 0.2 to 0.8% by weight of sodium lauryl sulfate,
c) 0.5-2% by weight of carrageenan,
d) 0.2 to 1% by weight of potassium chloride,
e) 0.5-2% by weight of crystalline cellulose and light anhydrous silicic acid,
f) 20 to 45% by weight of sorbitol,
The stable jelly composition of amlodipine according to claim 12, wherein
JP2008178569A 2007-07-10 2008-07-09 Amlodipine stable solution and jelly Expired - Fee Related JP5072748B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008178569A JP5072748B2 (en) 2007-07-10 2008-07-09 Amlodipine stable solution and jelly

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007180579 2007-07-10
JP2007180579 2007-07-10
JP2008178569A JP5072748B2 (en) 2007-07-10 2008-07-09 Amlodipine stable solution and jelly

Publications (3)

Publication Number Publication Date
JP2009035545A JP2009035545A (en) 2009-02-19
JP2009035545A5 true JP2009035545A5 (en) 2010-05-20
JP5072748B2 JP5072748B2 (en) 2012-11-14

Family

ID=40437775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008178569A Expired - Fee Related JP5072748B2 (en) 2007-07-10 2008-07-09 Amlodipine stable solution and jelly

Country Status (1)

Country Link
JP (1) JP5072748B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4509118B2 (en) * 2004-10-06 2010-07-21 エルメッド エーザイ株式会社 PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THE SAME, AND METHOD FOR STABILIZING DIHYDROPYRIDINE COMPOUNDS
EP2815747B8 (en) * 2012-02-14 2018-06-27 Kyukyu Pharmaceutical Co., Ltd. Intraoral soluble-type film preparation
IL279121B2 (en) * 2018-06-01 2024-06-01 Tavanta Therapeutics Hungary Incorporated Topical amlodipine salts for the treatment of anorectal diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3424553A1 (en) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen SOLID DRUG PREPARATIONS WITH DIHYDROPYRIDINE AND METHOD FOR THE PRODUCTION THEREOF
JP4439499B2 (en) * 2005-08-01 2010-03-24 大日本住友製薬株式会社 Amlodipine-containing particles and orally disintegrating tablets comprising the same
JP2009256216A (en) * 2008-04-14 2009-11-05 Towa Yakuhin Kk Liquid amlodipine besylate formulation for internal administration stable in solution state

Similar Documents

Publication Publication Date Title
JP2002543953A5 (en)
JP2013529072A5 (en)
WO2007131088A3 (en) Oral rehydration compositions
RU2012150279A (en) ENZYMAN GRANULES
BR112012018384A2 (en) solid pharmaceutical composition with enhancers and methods of preparation thereof.
JP2013193968A5 (en)
JP2013516388A5 (en)
ATE443754T1 (en) CLEAR DETERGENT AND CLEANING AGENT WITH FLOW LIMIT
JP2009522402A5 (en)
RS51135B (en) Fexofenadine suspension formulation
JP2009035545A5 (en)
DK2151241T3 (en) STABLE SOLID PREPARATION, INCLUDING 4,5-EPOXYMORPHINANDER DERIVATIVE
RU2015123446A (en) STABLE COMPOSITIONS CONTAINING METAL ION
JP2007533712A5 (en)
NZ599377A (en) Salts, aqueous liquid compositions containing salts of S-(+)-abscisic acid and methods of their preparation
PH12014501981A1 (en) Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
BR112021014161A2 (en) EXTRUDED SOAP BAR AND PROCESSES TO PREPARE A SOAP BAR
JP2023165999A5 (en)
BRPI0519819A2 (en) aqueous fabric softening composition
RU2016100744A (en) ORGANIC CARE COMPOSITIONS
AR087371A1 (en) FORMULATIONS OF (TRIMETOXIFENILAMINO) PYRIMIDINYL, METHODS
JP2014172882A5 (en)
US20190367848A1 (en) Dishwashing Pastes
JP2009067947A5 (en)
RU2014153494A (en) COMPOSITION FOR CARE OF THE ORAL CAVITY